Recent Updates
Recently added Catalysts
KURA Neutral Sentiment Score: 60/100

Kura Oncology to Report Second Quarter 2025 Financial Results

Thursday, July 31, 2025 1 min read
Key Takeaway: Kura Oncology, a clinical-stage biopharmaceutical firm, will report its financial results for the second quarter of 2025 on August 7, 2025. Following the report, the company's management is scheduled to host a webcast and conference call to discuss the results and give an update on corporate developments. Interested parties can access the call through provided dial-in numbers as well as a live webcast.

Market Sentiment Analysis

POSITIVE FACTORS

  • Kura Oncology is committed to precision medicines for cancer treatments.
  • The upcoming financial results report is an opportunity to assess company performance.
  • The management will provide a corporate update during the conference call.

Full Press Release Details

SAN DIEGO, July 31, 2025 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced it will report second quarter 2025 financial results after the close of U.S. financial markets on Thursday, August 7, 2025. Kura’s management will host a webcast and conference call at 4:30 p.m. ET / 1:30 p.m. PT to discuss the financial results and provide a corporate update.
The live call may be accessed by dialing (800) 579-2543 for domestic callers and (785) 424-1789 for international callers and entering the conference ID: KURAQ2. A live webcast and archived replay of the event will be available here or online from the investor relations section of the Company’s website at www.kuraoncology.com.
Investors and media:
gmann@kuraoncology.com

Frequently Asked Questions

When will Kura Oncology report its Q2 2025 results?

Kura Oncology will report its Q2 2025 financial results on August 7, 2025.

What time is the Kura Oncology conference call?

The conference call will begin at 4:30 p.m. ET / 1:30 p.m. PT.

How can I access the Kura Oncology conference call?

Dial (800) 579-2543 for domestic or (785) 424-1789 for international access.

Is there a way to listen to the conference call later?

Yes, an archived replay will be available on Kura's investor relations website.

How can investors contact Kura Oncology?

Investors can contact Kura Oncology at gmann@kuraoncology.com.

Tags: KURA Viatris Investor Conferences Healthcare Kura Oncology financial results Q2 2025 biopharmaceutical cancer treatment
Last updated: Jul 31, 2025